Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Antigenic peptide molecular recognition by the DRB1-DQB1 haplotype modulates multiple sclerosis susceptibility.
Study of curcumin immunomodulatory effects on reactive astrocyte cell function.
Identification of a Selective RORγ Ligand That Suppresses T(H)17 Cells and Stimulates T Regulatory Cells.
Functional magnetic resonance imaging movers and shakers: Does subject-movement cause sampling bias?
Tract-specific quantitative MRI better correlates with disability than conventional MRI in multiple sclerosis.
CD226 ligation protects against EAE by promoting IL-10 expression via regulation of CD4+ T cell differentiation.
IL-17A is implicated in lipopolysaccharide-induced neuroinflammation and cognitive impairment in aged rats via microglial activation.
Is there an association between the Expanded Disability Status Scale and inflammatory markers in multiple sclerosis?
Central Nervous System Infections With Immunomodulatory Therapies.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Exposure to serotonin adversely affects oligodendrocyte development and myelination in vitro.
Polyclonal immunoglobulin G for autoimmune demyelinating nervous system disorders.
A review of the cultivation and processing of cannabis (Cannabis sativa L.) for production of prescription medicines in the UK.
Central Nervous System Demyelination in a Charcot-Marie-Tooth Type 1A Patient.
Meningoencephalitis as an initial manifestation of neuromyelitis optica spectrum disorder.
Altered cardiovascular reactivity to mental stress in patients with multiple sclerosis.
Identification of a microglia phenotype supportive of remyelination.
Detailing intra-lesional venous lumen shrinking in multiple sclerosis investigated by sFLAIR MRI at 7-T.
Using magnetic resonance imaging as a means to study chronic cerebral spinal venous insufficiency in multiple sclerosis patients.
Uveitis- a rare disease often associated with systemic diseases and infections- a systematic review of 2619 patients.
Preferential uptake of antioxidant carbon nanoparticles by T lymphocytes for immunomodulation.
Multifocal Acquired Demyelinating Sensory and Motor Neuropathy: Unexpected Diagnosis After Ultrasound Imaging for a Humeral Fracture.
ENDOCANNABINOID SYSTEM: A multi-facet therapeutic target.
Patient Preferences for Injectable Treatments for Multiple Sclerosis in the United States: A Discrete-Choice Experiment.
Adolescent-onset Krabbe disease with an initial diagnosis of multiple sclerosis and a novel mutation.
Pages
« first
‹ previous
…
384
385
386
387
388
389
390
391
392
…
next ›
last »